The aim of this project is to see if we can use hyperpolarised xenon-MRI to understand in much more detail the effects of COVID-19 on the lungs. We’re particularly interested in how long the symptoms last and whether we can identify areas on scans that may be the cause of long-lasting symptoms.
Professor Fergus Gleeson launched a study which identified lung abnormalities in long COVID patients during scans using hyperpolarised xenon gas, which were not shown during routine scans.
Hyperpolarised xenon gas behaves very similarly to oxygen, but it can also be seen during scans, which means scientists can witness it move into the bloodstream, as oxygen would.
The purpose of this study is to understand in much more detail the effects of COVID-19 on the lungs. We are particularly interested in how long symptoms last and whether we can identify areas on scans that may be the cause of long lasting symptoms.
In some people, the symptoms of COVID-19 can continue for many months after the infection, which may adversely affect their quality of life. For example, many people complain of persistent breathlessness and fatigue. The virus may affect the function of the lung in ways that are not yet fully understood.
Video case study: NCIMI
March 28, 2023
NCIMI is fundamentally about supporting AI development in a radiology context. And what we’re doing is helping our industry partners…
NCIMI impact report
March 20, 2023
NCIMI draws to a close
March 20, 2023
Video case study: Automated detection of spinal cancer on MRI
March 16, 2023